NHS England (NHSE) and PSNC have decided that the current year’s clinical audit (2022/23), will aim at “reducing the potential harm caused by taking valproate during pregnancy”, the negotiator revealed in an update yesterday (November 15).
Free to registered users
Register to gain full access to C+D and C+D Community content
Already registered?